Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
NVCR Novocure
94.220-0.870-0.91%
Close
02/03 16:00 ET
94.2200.0000.00%
Post Mkt Price 02/03 16:04 ET
High
95.125
Open
93.620
Turnover
69.67M
Low
92.200
Pre Close
95.090
Volume
743.07K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Novocure: Statement of acquisition of beneficial ownership by individuals(Amendment)
SC 13G/A | NovoCure Ltd (0001645113) (Subject)
Novocure: Statement of acquisition of beneficial ownership by individuals(Amendment)
SC 13G/A | NovoCure Ltd (0001645113) (Subject)
Novocure: Statement of changes in beneficial ownership of securities
4 | NovoCure Ltd (0001645113) (Issuer)
Novocure: Statement of changes in beneficial ownership of securities
4 | NovoCure Ltd (0001645113) (Issuer)
Novocure: Statement of changes in beneficial ownership of securities
4 | NovoCure Ltd (0001645113) (Issuer)
Novocure: Statement of changes in beneficial ownership of securities
4 | NovoCure Ltd (0001645113) (Issuer)
Novocure: Statement of changes in beneficial ownership of securities
4 | NovoCure Ltd (0001645113) (Issuer)
Novocure: Statement of changes in beneficial ownership of securities
4 | NovoCure Ltd (0001645113) (Issuer)
Novocure: Statement of changes in beneficial ownership of securities
4 | NovoCure Ltd (0001645113) (Issuer)
Novocure: Statement of changes in beneficial ownership of securities
4 | NovoCure Ltd (0001645113) (Issuer)
Company Overview
More
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
CEO： Mr. Asaf Danziger
Market： NASDAQ
Listing Date： 10/02/2015
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet